Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs
<p>Abstract</p> <p>Background</p> <p>CJ9-gD is a novel dominant-negative recombinant herpes simplex virus type 1 (HSV-1) that is completely replication-defective, cannot establish detectable latent infection <it>in </it>vivo, and expresses high levels of the...
Հիմնական հեղինակներ: | Brans Richard, Yao Feng |
---|---|
Ձևաչափ: | Հոդված |
Լեզու: | English |
Հրապարակվել է: |
BMC
2010-06-01
|
Շարք: | BMC Microbiology |
Առցանց հասանելիություն: | http://www.biomedcentral.com/1471-2180/10/163 |
Նմանատիպ նյութեր
-
A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigs.
: Pengwei Zhang, և այլն
Հրապարակվել է: (2014-01-01) -
An Adenovirus-Based Recombinant Herpes Simplex Virus 2 (HSV-2) Therapeutic Vaccine Is Highly Protective against Acute and Recurrent HSV-2 Disease in a Guinea Pig Model
: Mingming Wan, և այլն
Հրապարակվել է: (2023-01-01) -
Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
: Kevin Egan, և այլն
Հրապարակվել է: (2020-09-01) -
Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs
: Jonathan D. Joyce, և այլն
Հրապարակվել է: (2021-03-01) -
Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.
: Jingya Xia, և այլն
Հրապարակվել է: (2014-01-01)